Citations for
1DIDO1, NANOG, POU5F1
The death-inducer obliterator 1 (Dido1) gene regulates embryonic stem cell self-renewal.
Liu Y, Kim H, Liang J, Lu W, Ouyang B, Liu D, Songyang Z.
J Biol Chem 289(8):4778-86. doi: 10.1074/jbc.M113.486290. Epub 2013 Dec 17. 2014
2DIDO1, PHF3
PHD and TFIIS-Like domains of the Bye1 transcription factor determine its multivalent genomic distribution.
Pinskaya M, Ghavi-Helm Y, Mariotte-Labarre S, Morillon A, Soutourina J, Werner M.
PLoS One 9(7):e102464. doi: 10.1371/journal.pone.0102464. eCollection 2014. 2014
3DIDO1, ITGA5
Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression.
Braig S, Bosserhoff AK.
Oncogene 32(7):837-48. doi: 10.1038/onc.2012.115. Epub 2012 Apr 2. 2013
4DIDO1
Dido3 PHD modulates cell differentiation and division.
Gatchalian J, Fütterer A, Rothbart SB, Tong Q, Rincon-Arano H, Sánchez de Diego A, Groudine M, Strahl BD, Martínez-A C, van Wely KH, Kutateladze TG.
Cell Rep 4(1):148-58. doi: 10.1016/j.celrep.2013.06.014. Epub 2013 Jul 3. 2013
5DIDO1, PHF3
Structures of RNA polymerase II complexes with Bye1, a chromatin-binding PHF3/DIDO homologue.
Kinkelin K, Wozniak GG, Rothbart SB, Lidschreiber M, Strahl BD, Cramer P.
Proc Natl Acad Sci U S A 110(38):15277-82. doi: 10.1073/pnas.1311010110. Epub 2013 Sep 3. 2013
6DIDO1
Ablation of Dido3 compromises lineage commitment of stem cells in vitro and during early embryonic development.
Fütterer A, Raya A, Llorente M, Izpisúa-Belmonte JC, de la Pompa JL, Klatt P, Martínez-A C.
Cell Death Differ 19(1):132-43. doi: 10.1038/cdd.2011.62. Epub 2011 Jun 10. 2012
7DIDO1
Synaptonemal complex assembly and H3K4Me3 demethylation determine DIDO3 localization in meiosis.
Prieto I, Kouznetsova A, Fütterer A, Trachana V, Leonardo E, Alonso Guerrero A, Cano Gamero M, Pacios-Bras C, Leh H, Buckle M, Garcia-Gallo M, Kremer L, Serrano A, Roncal F, Albar JP, Barbero JL, Martínez-A C, van Wely KH.
Chromosoma 118(5):617-32. doi: 10.1007/s00412-009-0223-7. Epub 2009 Jun 26. 2009
8DIDO1
Dido disruption leads to centrosome amplification and mitotic checkpoint defects compromising chromosome stability.
Trachana V, van Wely KH, Guerrero AA, Futterer A, Martinez-A C.
Proc Natl Acad Sci U S A [Epub ahead of print] 2007
9DIDO1
Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms.
Futterer A, Campanero MR, Leonardo E, Criado LM, Flores JM, Hernandez JM, San Miguel JF, Martinez-A C.
J Clin Invest 115(9):2351-62. Epub 2005 Aug 25. 2005
10CGRRF1, CD34, DIDO1, RBAK
Novel transcription factors in human CD34 antigen-positive hematopoietic cells.
Gomes I, Sharma TT, Edassery S, Fulton N, Mar BG, Westbrook CA.
Blood 100(1):107-19. 2002
11DIDO1
DIO-1 is a gene involved in onset of apoptosis in vitro, whose misexpression disrupts limb development.
Garcia-Domingo D, Leonardo E, Grandien A, Martinez P, Albar JP, Izpisua-Belmonte JC, Martinez-A C.
Proc Natl Acad Sci U S A 96(14):7992-7. 1999
12ADAMTS3, AKAP6, ALMS1, ANKRD28, AREL1, ARHGEF10, ARHGEF11, ARHGEF17, ARNT2, BAZ2A, CABIN1, CAST, CHD9, CIC, CLEC16A, CLOCK, CTNND1, DCLK1, DDX46, DIDO1, DNAH9, DNM3, DOCK3, DYNC1H1, ECM29, ENTPD4, EPB41L1, EZH1, FAM65B, FRMPD4, GCC2, HECW1, HERC2, HISPPD1, HUWE1, IGSF1, KAT6B, KIAA0319, KIAA0323, KIAA0355, KIAA0379, KIF3B, KMT2B, LBA1, MADD, MAST4, MCF2L, MDN1, MTMR3, MYO6, N4BP3, NACAD, NRCAM, PCDH9, PCDHGA8, PCDHGC3, PDZD2, PER2, PFAS, PLEKHM1, PLXNB2, PRORP, PRUNE2, PTPRN2, RAPGEF2, RIMBP2, RIMS1, RUSC2, SALL2, SEC16A, SEMA3C, SEMA3E, SETD1A, SFRS14, SNPH, SPECC1L, SPTBN2, SR140, SRCAP, SRRM2, SYNJ2, TECPR2, TLN2, TRIM66, TTC37, UBR2, WNK1, XPO6, ZBTB39, ZBTB5, ZFYVE16, ZFYVE26, ZMYM3, ZNF518A, ZNF609, ZNF629, ZNF646
Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.
Nagase T, Ishikawa K, Nakajima D, Ohira M, Seki N, Miyajima N, Tanaka A,Kotani H, Nomura N, Ohara O.
DNA Res 4(2):141-50. 1997